Rosmantuzumab: A Deep Dive into OMP-131R10 Rosmantuzumab, previously known through OMP-131R10, constitutes a new monoclonal immunoglobulin engineered to inhibit granulocyte-macrophage colony-stimulating factor. Its https://www.targetmol.com/compound/rosmantuzumab